UK Companies House feature
BROWN & BURK UK LIMITED
Cash
£5M
+30.4% vs 2024
Net assets
£21M
+21.2% vs 2024
Employees
20
0% vs 2024
Profit before tax
£5M
-31.2% vs 2024
Profile
- Company number
- 04082256
- Status
- Active
- Incorporation
- 2000-10-02
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Net assets
7-year trend · vs UK Healthcare median
Accounts
7-year trend · latest 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | £21,509,785 | — | £20,910,232 | — | — | — | |
| Operating profit | — | £3,017,333 | — | £598,860 | — | — | — | |
| Profit before tax | — | £2,766,277 | — | £571,457 | £6,497,270 | £6,904,368 | £4,748,742 | |
| Net profit | — | £2,227,537 | — | £727,525 | £5,283,071 | £5,285,162 | £3,601,679 | |
| Cash | — | £3,304,785 | — | £6,172,728 | £6,439,501 | £3,489,237 | £4,550,729 | |
| Total assets less current liabilities | — | £11,022,371 | — | £18,216,520 | £17,384,254 | £17,163,695 | £20,740,500 | |
| Net assets | — | £6,232,431 | — | £6,382,466 | £11,665,537 | £16,950,699 | £20,552,378 | |
| Equity | £4,004,894 | £6,232,431 | £5,654,941 | £6,382,466 | £11,665,537 | £16,950,699 | £20,552,378 | |
| Average employees | — | 7 | — | 21 | 19 | 20 | 20 | |
| Wages | — | £462,673 | — | £992,257 | £1,184,323 | £1,393,916 | £1,391,582 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Brown & Burk AB · 100% held · Sweden · Pharmaceutical distributor
- Brown & Burk IR Limited · 100% held · Ireland · Pharmaceutical distributor
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HIREMAT, Preetham Sharma | Director | 2005-08-01 | Jun 1973 | British |
| IBRAMPUR, Badarinath | Director | 2013-10-03 | Jul 1966 | Indian |
| JAIN, Ashok Kumar | Director | 2013-10-03 | Sep 1956 | Indian |
| SUBRAMANI, Jagadish | Director | 2021-04-01 | Jul 1979 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LOWRY, Elizabeth | Secretary | 2000-10-02 | 2000-10-02 |
| SURANA, Anand | Secretary | 2000-10-02 | 2007-05-18 |
| WHITTINGHAM, Ivan John | Secretary | 2007-05-18 | 2016-05-23 |
| ANAND, Surana | Director | 2011-07-01 | 2013-10-03 |
| GABA, Arun | Director | 2000-10-02 | 2005-08-01 |
| GAUBA, Arun | Director | 2006-02-27 | 2006-05-31 |
| IYER, Sriram Venkatraman | Director | 2011-07-01 | 2013-06-24 |
| MORRIS, Mary Lois | Director | 2000-10-02 | 2000-10-02 |
| SUBRAMANI, Jagadish | Director | 2014-04-01 | 2015-10-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Surana Anand | Individual | Significant influence | 2016-04-06 | Active |
Filing timeline
Last 20 of 91 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-11-11 | AA | accounts | accounts with accounts type full |
| 2025-10-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-11 | AA | accounts | accounts with accounts type full |
| 2023-10-06 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-09-08 | AA | accounts | accounts with accounts type full |
| 2022-10-10 | CH01 | officers | change person director company with change date |
| 2022-10-10 | CH01 | officers | change person director company with change date |
| 2022-10-10 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-08-24 | AA | accounts | accounts with accounts type full |
| 2021-10-06 | CS01 | confirmation-statement | confirmation statement with updates |
| 2021-08-10 | AA | accounts | accounts with accounts type full |
| 2021-05-20 | AP01 | officers | appoint person director company with name date |
| 2020-11-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-08-07 | AA | accounts | accounts with accounts type full |
| 2019-10-18 | CS01 | confirmation-statement | confirmation statement with updates |
| 2019-07-18 | AA | accounts | accounts with accounts type full |
| 2018-10-02 | CH01 | officers | change person director company with change date |
| 2018-10-02 | CS01 | confirmation-statement | confirmation statement with updates |
| 2018-08-20 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
4.11
SAFE
Altman Z″
- Working capital / Total assets 0.321 × 6.56 = +2.11
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.122 × 6.72 = +0.82
- Book equity / Total liabilities 1.127 × 1.05 = +1.18
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory